P1 Familial risk of cancer: Data for clinical counseling and cancer genetics
- 作者Xinjun Li; Kamila Czene; Kari Hemminki
- 卷第2卷
- 期第1期
- 文件大小130.44KB
- 发表时间2004
- DOI10.1016/s1359-6349(04)90120-6
Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors: S17. Aromatase inhibitors in breast cancer prevention: The IBIS-II trialJ. Cuzick · 2004
Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors: S18. Breast cancer chemoprevention: Quo vadis?T. Powles · 2004
Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors: S15. The US breast cancer-prevention trials (NSABP-P1, MORE, STAR)V. Vogel; D. Wickerham; J. Costantino; W. Cronin; N. Wolmark · 2004
Fenretinide and cancer preventionRosalba Torrisi; Andrea Decensi · 2000
Endocrine therapy in ovarian cancerPaleari, Laura; DeCensi, Andrea · Current Opinion in Obstetrics and Gynecology · 2017
An Abstract Provides “seAFOod” for ThoughtDeCensi, Andrea; Gescher, Andreas · Cancer Prevention Research · 2019
Pharmacological prevention of breast cancer: Quo vadis?Andrea Decensi · 2003
Progress in chemoprevention of breast cancerDavide Serrano; Elisa Perego; Alberto Costa; Andrea Decensi · 2004
SERMs in chemoprevention of breast cancerMilena Gasco; Alessandra Argusti; Bernardo Bonanni; Andrea Decensi · 2005
Retinoids and tamoxifen in breast cancer chemopreventionAlberto Costa; Virgilio Sacchini; Andrea Decensi · 1993
Breast Cancer Prevention Trials Using RetinoidsAndrea Decensi; Davide Serrano; Bernardo Bonanni; Massimiliano Cazzaniga; Aliana Guerrieri-Gonzaga · 2003